Salarius Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results
Conference Call and Live Audio Webcast Scheduled for Thursday, March 18, 2021, 4:30 p.m. ETHOUSTON, March 11, 2021 (GLOBE NEWSWIRE)...
Month: March 2021
Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Received IND clearance and initiated first-in-human Phase 1 clinical trial for lead asset, ADI-001, an anti-CD20 allogeneic CAR gamma-delta T...
Homology Medicines Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
- Phase 2 PKU Gene Therapy Trial Recruiting Patients With Initial Data Expected by Year End - - On Track...
Spero Therapeutics Announces Fourth Quarter and Full-Year 2020 Operating Results and Provides Business Update
Tebipenem HBr advancing towards NDA submission in the second half of 2021 Conference call and live webcast at 4:30 p.m. EST today CAMBRIDGE,...
Nabriva Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Updates
-Relaunched XENLETA® (lefamulin) and SIVEXTRO® (tedizolid phosphate) in the community with 60 sales representatives- -Nabriva plans to initiate a Phase...
The Ensign Group to Present at the Oppenheimer & Co. Inc. 31st Annual Healthcare Conference
SAN JUAN CAPISTRANO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group...
electroCore Announces Fourth Quarter and Full Year 2020 Financial Results
Full year 2020 net sales of approximately $3.5 million increased 46% over $2.4 million for full year 2019 Further reduced...
Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
VANCOUVER and MINNEAPOLIS, March 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX:...
Revolution Medicines Announces Six Presentations at the American Association for Cancer Research Annual Meeting 2021
Presentations Highlight Continued Progress Across Expanded R&D Pipeline of RAS(ON) Inhibitors and RAS Companion InhibitorsREDWOOD CITY, Calif., March 11, 2021...
Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update
Conference call begins at 4:30 p.m. Eastern time today NEWTOWN, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc....
CareDx Names Ankur Dhingra as New Chief Financial Officer
SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on...
Lumos Pharma to Participate in March 2021 Investor Conferences
AUSTIN, Texas, March 11, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare...
Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results
HAUPPAUGE, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on...
Regional Winners of 29th Annual ExploraVision Competition Announced by Toshiba and National Science Teaching Association
Twenty-Three Winning Teams Recognized for Innovative Solutions to the World’s Challenges ARLINGTON, Va.--(BUSINESS WIRE)--Toshiba and the National Science Teaching Association...
Relief Announces CHF 10 Million Private Placement
GENEVA, SWITZERLAND / ACCESSWIRE / March 12, 2021 / RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the...
Psychedelic Expert Core One Labs Reports Milestone Acquisition
The Developer of Psychedelic Treatments Enters the Telehealth Space with Access to Close to 80,000 Clinic Patients VANCOUVER, BC /...
Dr. Lori Shemek Recognized as No. 1 Top 10 Health & Wellness Global Influencer
ALBANY, GA / ACCESSWIRE / March 11, 2021 / Dr. Lori Shemek, a certified nutritionist and weight loss expert has...
Dr. Neil Hattangadi Joins Intersect ENT’s Board of Directors
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to...
Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN), along with researchers at the University of Colorado and Harvard Pilgrim Health Care (HPHC),...
Achieve Reports Financial Results for Fourth Quarter and Year-End 2020 and Provides Corporate Update
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / March 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical...